Subscribe to our Email Alerts

PROACTIVE INTERVIEW | Dr Chris Burns discusses Amplia's collaboration with CSIRO


Amplia's CEO & MD, Dr Chris Burns, spoke with Andrew Scott at Proactive about the Company's upcoming research collaboration with CSIRO to investigate the development of topical formulations of its FAK inhibitors to aid wound healing and reduce scarring.

Watch it here.